Ati cautat: studii clinice

Protocol terapeutic: L04AA25-SHUa – DCI ECULIZUMABUM (actualizat MARTIE 2022 conform ordin MS/CNAS NR 702/133/2022)

Protocol terapeutic: L04AA25-HPN – DCI ECULIZUMABUM (actualizat MARTIE 2022 conform ordin MS/CNAS NR 702/133/2022)

Protocol terapeutic: L01EK03 – DCI TIVOZANIBUM (actualizat MARTIE 2022 conform ordin MS/CNAS NR 702/133/2022)

Protocol terapeutic: A16AX08 – DCI TEDUGLUTIDUM (actualizat MARTIE 2022 conform ordin MS/CNAS NR 702/133/2022)

Protocol terapeutic: R03DX05-UCS – URTICARIE CRONICĂ SPONTANĂ – TERAPIE BIOLOGICĂ (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: N07XX11 – DCI PITOLISANTUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: B02BX06 – DCI EMICIZUMAB (actualizat APRILIE 2022 conform ordin MS/CNAS NR 1206/233/2022)

Protocol terapeutic: A10BD24 – DCI COMBINAȚII ERTUGLIFLOZINUM + SITAGLIPTINUM (actualizat APRILIE 2022 conform ordin MS/CNAS NR 1206/233/2022)

Protocol terapeutic: M09AX10 – DCI RISDIPLAMUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: J02AB02 – DCI KETOCONAZOLUM (comprimate 200 MG) (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)